Malawi vs World: Access to anti-retroviral drugs, male
Malawi
90.0%
in 2024
World
73.0%
in 2024
Malawi rank
13th
World rank
15th
Access to anti-retroviral drugs, male over time
- Malawi
- World
How they compare
Malawi currently reports 90.0% against 73.0% in World, a difference of 17.0%.
That makes Malawi's figure about 1.2 times World's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was World ahead.
Malawi ranks 13th and World ranks 15th of 141 countries.
Across the 3 decades both report, Malawi averaged higher in 2 and World in 1.
Head to head by decade
| Decade | Malawi | World | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.3% | 7.1% | 0.8% | World |
| 2010s | 55.4% | 40.6% | 14.8% | Malawi |
| 2020s | 86.8% | 67.6% | 19.2% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Malawi or World?
- Malawi, at 90.0% against 73.0% in World as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Malawi and World?
- 17.0%, with Malawi ahead.
- How many years of comparable data are there for Malawi and World?
- 25 years are reported by both, from 2000 to 2024.
- How do Malawi and World rank globally for access to anti-retroviral drugs, male?
- Malawi ranks 13th and World ranks 15th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.